⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent rectal cancer

Every month we try and update this database with for recurrent rectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedNCT00025337
Adenocarcinoma ...
Adenocarcinoma ...
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
18 Years - National Cancer Institute (NCI)
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverNCT00492999
Colorectal Canc...
Metastatic Canc...
dexamethasone
floxuridine
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerNCT00016198
Colorectal Canc...
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046
Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerNCT00274885
Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI)
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerNCT00134069
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
sorafenib tosyl...
cetuximab
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerNCT00640081
Colorectal Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
immunohistochem...
laboratory biom...
18 Years - 100 YearsMedical Research Council
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerNCT00049101
Colorectal Canc...
erlotinib hydro...
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerNCT00062426
Colorectal Canc...
bevacizumab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Gemcitabine in Treating Patients With Advanced Colorectal CancerNCT00007943
Colorectal Canc...
gemcitabine hyd...
18 Years - 120 YearsWake Forest University Health Sciences
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal CancerNCT00027729
Colorectal Canc...
etaracizumab
18 Years - Memorial Sloan Kettering Cancer Center
Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerNCT00004870
Colorectal Canc...
oblimersen sodi...
irinotecan hydr...
18 Years - The University of Texas Health Science Center at San Antonio
Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal CancerNCT00504153
Recurrent Colon...
Recurrent Recta...
Stage IV Colon ...
Stage IV Rectal...
dasatinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerNCT00571740
Colorectal Canc...
bevacizumab
cetuximab
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - Alliance for Clinical Trials in Oncology
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerNCT00008281
Colorectal Canc...
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerNCT00005076
Colorectal Canc...
cetuximab
irinotecan hydr...
18 Years - University of Alabama at Birmingham
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerNCT01105377
Recurrent Colon...
Recurrent Recta...
Stage IV Colon ...
Stage IV Rectal...
entinostat
azacitidine
laboratory biom...
18 Years - National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520
Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal CancerNCT00002828
Colorectal Canc...
fluorouracil
raltitrexed
18 Years - Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Colorectal CancerNCT00006103
Colorectal Canc...
fluorouracil
irinotecan hydr...
leucovorin calc...
- Alliance for Clinical Trials in Oncology
SarCNU in Treating Patients With Recurrent or Metastatic Colorectal CancerNCT00028015
Colorectal Canc...
SarCNU
18 Years - 120 YearsCanadian Cancer Trials Group
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerNCT00049101
Colorectal Canc...
erlotinib hydro...
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal CancerNCT00027729
Colorectal Canc...
etaracizumab
18 Years - Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerNCT00008060
Colorectal Canc...
FOLFIRI regimen
FOLFOX regimen
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Irinotecan in Treating Patients With Colorectal CancerNCT00003843
Colorectal Canc...
irinotecan hydr...
mutation analys...
polymorphism an...
18 Years - California Cancer Consortium
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046
Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center
SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerNCT00006001
Colorectal Canc...
semaxanib
18 Years - National Cancer Institute (NCI)
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryNCT00835679
Liver Metastase...
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
cetuximab
dasatinib
therapeutic con...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsNCT00138177
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
Unspecified Adu...
oxaliplatin
leucovorin calc...
vorinostat
fluorouracil
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerNCT00482222
Colorectal Canc...
Metastatic Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
study of socioe...
adjuvant therap...
neoadjuvant the...
quality-of-life...
18 Years - University of Southampton
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal CancerNCT00024401
Colorectal Canc...
DHA-paclitaxel
18 Years - National Cancer Institute (NCI)
SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilNCT00003254
Colorectal Canc...
ethynyluracil
fluorouracil
18 Years - SWOG Cancer Research Network
Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerNCT00003446
Colorectal Canc...
fluorouracil
leucovorin calc...
trimetrexate gl...
18 Years - 74 YearsNational Cancer Institute (NCI)
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerNCT00008281
Colorectal Canc...
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal CancerNCT00655499
Colorectal Canc...
Panitumumab
Irinotecan hydr...
Chromogenic in ...
Fluorescence in...
Gene expression...
Laboratory biom...
18 Years - 80 YearsGERCOR - Multidisciplinary Oncology Cooperative Group
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerNCT01320683
Liver Metastase...
Recurrent Colon...
Recurrent Recta...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
oxaliplatin
leucovorin calc...
fluorouracil
bevacizumab
yttrium Y 90 DO...
laboratory biom...
pharmacological...
irinotecan hydr...
18 Years - City of Hope Medical Center
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyNCT01164215
Colorectal Canc...
Diarrhea
Neutropenia
fluorouracil
leucovorin
oxaliplatin
- UNC Lineberger Comprehensive Cancer Center
Selumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsNCT01217450
Recurrent Colon...
Recurrent Recta...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
Unspecified Adu...
selumetinib
cetuximab
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsNCT01233505
Adenocarcinoma ...
Adenocarcinoma ...
BRCA1 Mutation ...
BRCA2 Mutation ...
Ovarian Mucinou...
Recurrent Breas...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Unspecified Adu...
veliparib
capecitabine
oxaliplatin
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerNCT00134069
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
sorafenib tosyl...
cetuximab
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal CancerNCT00899210
Colorectal Canc...
Metastatic Canc...
laboratory biom...
cryosurgery
radiofrequency ...
therapeutic con...
18 Years - National Cancer Institute (NCI)
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal CancerNCT02528175
Recurrent Recta...
Magnetic resona...
Standard Radiat...
Chemotherapy
18 Years - Sunnybrook Health Sciences Centre
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerNCT00022477
Colorectal Canc...
BMS-247550
18 Years - University of Chicago
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerNCT00006269
Colorectal Canc...
Diarrhea
irinotecan hydr...
octreotide acet...
18 Years - Novartis
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerNCT02041481
Recurrent Colon...
Recurrent Recta...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
MEK inhibitor M...
leucovorin calc...
fluorouracil
oxaliplatin
pharmacological...
Laboratory Biom...
18 Years - City of Hope Medical Center
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerNCT00075595
Colorectal Canc...
FOLFIRI regimen
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 YearsNational Cancer Institute (NCI)
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerNCT00640081
Colorectal Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
immunohistochem...
laboratory biom...
18 Years - 100 YearsMedical Research Council
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal CancerNCT00081237
Colorectal Canc...
OSI-7904L
oxaliplatin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266
Colorectal Canc...
Metastatic Canc...
bevacizumab
cetuximab
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
laboratory biom...
adjuvant therap...
biopsy
conventional su...
neoadjuvant the...
18 Years - 70 YearsNational Cancer Institute (NCI)
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerNCT00438737
Colorectal Canc...
Metastatic Canc...
bevacizumab
cetuximab
fluorouracil
leucovorin calc...
oxaliplatin
adjuvant therap...
conventional su...
neoadjuvant the...
18 Years - 80 YearsNational Cancer Institute (NCI)
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerNCT00296062
Colorectal Canc...
Unspecified Adu...
bevacizumab
capecitabine
irinotecan hydr...
oxaliplatin
18 Years - Case Comprehensive Cancer Center
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversNCT00684801
Colorectal Canc...
Lung Cancer
Ovarian Cancer
Pancreatic Canc...
questionnaire a...
quality-of-life...
18 Years - Case Comprehensive Cancer Center
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerNCT00003001
Colorectal Canc...
fluorouracil
gemcitabine hyd...
leucovorin calc...
- National Cancer Institute (NCI)
Genetic Study of Patients and Families With a History of Colorectal CancerNCT00003648
Colorectal Canc...
DNA stability a...
gene rearrangem...
- Alliance for Clinical Trials in Oncology
Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal CancerNCT00628810
Colorectal Canc...
bevacizumab
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 74 YearsFederation Francophone de Cancerologie Digestive
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerNCT00003427
Anal Cancer
Colorectal Canc...
Esophageal Canc...
Extrahepatic Bi...
Gallbladder Can...
Gastric Cancer
Gastrointestina...
Liver Cancer
Pancreatic Canc...
Small Intestine...
irinotecan hydr...
oxaliplatin
18 Years - Memorial Sloan Kettering Cancer Center
Liposomal SN-38 in Treating Patients With Metastatic Colorectal CancerNCT00311610
Colorectal Canc...
SN-38 liposome
18 Years - 120 YearsAlliance for Clinical Trials in Oncology
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryNCT00004895
Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Nausea and Vomi...
Ovarian Cancer
Pancreatic Canc...
Peritoneal Cavi...
Small Intestine...
octreotide acet...
18 Years - Northwestern University
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With BevacizumabNCT01814501
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
panitumumab
irinotecan hydr...
fluorouracil
leucovorin calc...
18 Years - Ohio State University Comprehensive Cancer Center
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerNCT00628368
Colorectal Canc...
Esophageal Canc...
gene expression...
mutation analys...
polymorphism an...
laboratory biom...
biopsy
endoscopic biop...
18 Years - National Cancer Institute (NCI)
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal CancerNCT00024401
Colorectal Canc...
DHA-paclitaxel
18 Years - National Cancer Institute (NCI)
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerNCT00002796
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
fluorouracil
sodium phenylbu...
indomethacin
recombinant int...
- National Cancer Institute (NCI)
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal CancerNCT00873275
Colorectal Canc...
bevacizumab
FOLFOX regimen
fluorouracil
leucovorin calc...
oxaliplatin
ursodiol
RNA analysis
gene expression...
polymerase chai...
western blottin...
immunohistochem...
laboratory biom...
pharmacological...
positron emissi...
18 Years - City of Hope Medical Center
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerNCT00025532
Colorectal Canc...
Esophageal Canc...
Gastric Cancer
Pancreatic Canc...
iodine I 131 mo...
19 Years - University of California, San Francisco
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerNCT00003439
Cancer
recombinant int...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal CancerNCT00628810
Colorectal Canc...
bevacizumab
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 74 YearsFederation Francophone de Cancerologie Digestive
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)NCT00023868
Colorectal Canc...
Metastatic Canc...
FOLFIRI regimen
cisplatin
doxorubicin hyd...
fluorouracil
irinotecan hydr...
leucovorin calc...
mitomycin C
18 Years - 120 YearsAmerican College of Radiology Imaging Network
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityNCT00003548
Cancer
aminocamptothec...
18 Years - NYU Langone Health
Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By SurgeryNCT01196000
Recurrent Recta...
Stage I Rectal ...
Stage II Rectal...
Stage III Recta...
conventional la...
robotic-assiste...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerNCT00003674
Breast Cancer
Colorectal Canc...
Lung Cancer
Prostate Cancer
Veno-occlusive ...
dalteparin
standard therap...
18 Years - Alliance for Clinical Trials in Oncology
BMS-247550 in Treating Patients With Metastatic Colorectal CancerNCT00033306
Colorectal Canc...
ixabepilone
Fluoropyrimidin...
Irinotecan
18 Years - University of Alabama at Birmingham
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681
Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI)
Radiation Therapy Plus Irinotecan in Treating Patients With Colon CancerNCT00003344
Colorectal Canc...
irinotecan hydr...
radiation thera...
18 Years - 120 YearsMedical University of South Carolina
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerNCT00100841
Adenocarcinoma ...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
cetuximab
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
18 Years - National Cancer Institute (NCI)
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerNCT01205022
Recurrent Colon...
Recurrent Recta...
Stage IV Colon ...
Stage IV Rectal...
irinotecan hydr...
leucovorin calc...
fluorouracil
bevacizumab
yttrium Y 90 DO...
laboratory biom...
18 Years - City of Hope Medical Center
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerNCT05628038
Recurrent Recta...
PD-1 antibody
Capecitabine
5FU
folinic acid
Oxaliplatin
Irinotecan
Raltitrexed
Radiation
18 Years - 75 YearsFudan University
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesNCT00062348
Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerNCT00004870
Colorectal Canc...
oblimersen sodi...
irinotecan hydr...
18 Years - The University of Texas Health Science Center at San Antonio
Cetuximab in Treating Patients With Stage IV Colorectal CancerNCT00020930
Colorectal Canc...
cetuximab
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: